Allison Swartz - 02 Nov 2026 Form 4 Insider Report for Progyny, Inc. (PGNY)

Reporting relationship: EVP, GC
Issuer ticker: PGNY
Reported as of: 02 Nov 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 04 Nov 2026, 16:18:52 UTC
Prior SEC filing: 28 Sep 2026
Source filing: View source filing
Reporting owner signature: /s/ Mark Livingston, Attorney-in-Fact

Filing notes and source

Key filing fact

Allison Swartz filed Form 4 for Progyny, Inc. (PGNY) on 04 Nov 2026.

Key facts

This page summarizes Allison Swartz's Form 4 filing for Progyny, Inc. (PGNY).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 04 Nov 2026, 16:18.

Change

Previous filing in this sequence was filed on 28 Sep 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001956339 Primary reporting owner

Swartz Allison

Relationship: EVP, GC
Address: C/O PROGYNY, INC., 1359 BROADWAY, 2ND FL, NEW YORK
Signature: /s/ Mark Livingston, Attorney-in-Fact
Signature date: 04 Nov 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PGNY transaction

Common Stock

Award

Transaction value
Shares: +8,160
Change %: +11%
Price: $0.000000^*
Shares after: 83,976
Date: 02 Nov 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PGNY transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares: +11,370
Change %
Price: $0.000000^*
Shares after: 11,370
Date: 02 Nov 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 11,370
Exercise price: $29.41
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents the number of shares of Issuer common stock underlying restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock. 33% of the RSUs shall vest on March 2, 2027, with the remainder vesting quarterly in equal installments thereafter through March 2, 2029, subject to the Reporting Person's continued service on each applicable vesting date.

Footnote F2

This option shall vest as follows: 33% shall vest on March 2, 2027, with the remainder vesting quarterly in equal installments thereafter through March 2, 2029, subject to the Reporting Person's continued service on each applicable vesting date.